Agenus (Formerly known as Antigenics Inc. - New York)

108 articles about Agenus (Formerly known as Antigenics Inc. - New York)

• New Phase 2 Data From Brain Cancer Study With Agenus (Formerly known as Antigenics Inc. - New York)' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS

  4/17/2012

• Agenus (Formerly known as Antigenics Inc. - Lexington, MA) and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines

  12/20/2011

• Mentor Capital Takes Investment Position in Each of 10 Cancer Immunotherapy Index Companies

  1/19/2010

• Antigenics Inc. (New York) Receives NASDAQ Delisting Notification

  1/4/2010

• Antigenics Inc. (New York) Cancer Vaccine Gets Negative EU Panel Vote

  11/20/2009

• Antigenics Inc. (New York) Buoyed by Brain-Cancer Study

  10/26/2009

• Antigenics Inc. (New York) to Report Third Quarter 2009 Financial Results on October 29, 2009; Conference Call to Follow

  10/22/2009

• Antigenics Inc. (Lexington, MA) to Raise $10 Million in Private Placement

  8/4/2009

• Antigenics Inc. (Lexington, MA) to Raise $10 Million in Private Placement

  7/31/2009

• Antigenics Inc. (New York) to Report Second Quarter 2009 Financial Results on July 30 2009; Conference Call to Follow

  7/23/2009

• Antigenics Inc. (New York) Regains NASDAQ Compliance

  4/30/2009

• Antigenics Inc. (New York) Brain Cancer Vaccine Gets Orphan Drug Status

  4/29/2009

• Antigenics Inc. (New York)’s Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer

  3/12/2009

• Antigenics Inc. (New York) Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights

  2/19/2009

• Antigenics Inc. (New York) to Report Fourth Quarter and Year-End 2008 Financial Results on February 19, 2009; Conference Call to Follow

  2/12/2009

• Antigenics Inc. (New York) Receives NASDAQ Delisting Notice

  12/23/2008

• Antigenics Inc. (New York) Receives NASDAQ Delisting Notification

  12/1/2008

• Antigenics Inc. (Lexington, MA) Vaccine Promising in Small Cancer Study

  11/24/2008

• Antigenics Inc. (New York) Reports Third Quarter 2008 Financial Results

  11/5/2008

• Antigenics Inc. (New York) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

  11/3/2008